SIGMA RECEPTOR-BINDING AGENT
PROBLEM TO BE SOLVED: To prepare a sigma receptor-binding pharmaceutincal agent highly effective in antagonism or pungency to a sigma receptor, having safety and useful as a preventive, therapeutical and ameliorative agent, etc., for schizophrenia and aporioneurosis by including a specific benzylpip...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | PROBLEM TO BE SOLVED: To prepare a sigma receptor-binding pharmaceutincal agent highly effective in antagonism or pungency to a sigma receptor, having safety and useful as a preventive, therapeutical and ameliorative agent, etc., for schizophrenia and aporioneurosis by including a specific benzylpiperidine derivative as an active component. SOLUTION: This pharmaceutical agent is prepared by including a benzylpiperidine of formula I [the bond of formula II is a single or double bond; R is an atomic group of formula III or the like; R is H or a lower alkoxy; (n) is 0-4] or its pharmacologically acceptable salt [e.g. 1-benzyl-4-(3,4- dihydro-4-oxoquinazolin-3-yl)piperidine, or the like] as an active component. The dose of the compound of formula I is pref. 1-500 mg/day and the pharmaceutical agent is oral administration, by intravenous injection, by intramuscular injection, by per rectum administration or by percutaneous administration. |
---|